• Publications
  • Influence
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
TLDR
This vaccine was efficacious in preventing rotavirus gastroenteritis, decreasing severe disease and health care contacts, and the risk of intussusception was similar in vaccine and placebo recipients. Expand
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.
TLDR
Most VZV infection occurred in childhood, but there was a wide variation in transmissibility, with R(0) ranging from 16.9 in the Netherlands to 3.3 in Italy, and herd immunity thresholds varied from 70% in Italy to 94% in the Dutch. Expand
Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.
TLDR
The results of the present study suggest that routine rotavirus vaccination for infants <6 months of age could significantly reduce the substantial burden of this potentially serious childhood disease. Expand
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe
TLDR
There is large variation in the seroepidemiology of herpes simplex virus types 1 and 2 in the general populations of eight European countries, particularly in northern Europe, and the observation that a significant proportion of adolescents are now HSV-1 susceptible may have implications for transmission and clinical presentation. Expand
Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey.
TLDR
The results of this large-scale airport survey clearly demonstrate an important educational need among those traveling to risk destinations and initiatives to improve such education should target all groups of travelers, including business travelers, those visiting friends and relatives, and the elderly. Expand
The global impact of vaccination against hepatitis B: a historical overview.
TLDR
The effective implementation of such programmes of vaccination has resulted in a substantial decrease in disease burden, in the carrier rate and in hepatitis B-related morbidity and mortality. Expand
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
TLDR
The safety and immunogenicity profiles of Ad26.COV2.S support further development of this vaccine candidate, and systemic adverse events were less common in cohort 3 than in cohort 1 and in those who received the low vaccine dose than in thoseWho received the high dose, while reactogenicity was lower after the second dose. Expand
Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study.
TLDR
Rotavirus genotypes G1-G4 and G9 are associated with the majority of RVGE infections in the areas studied, with geographic and seasonal variation in the distributions of rotavirus strains. Expand
Rotavirus disease and vaccination: impact on genotype diversity.
TLDR
It appears that the total number of hospitalizations due to rotavirus infections is being reduced, at least in developed countries that implemented a universal immunization program, however, continued surveillance is warranted, especially regarding the long-term effects of the vaccines. Expand
Rationale for pertussis booster vaccination throughout life in Europe.
TLDR
Recommendations for use of pertussis booster vaccinations at different ages are proposed to reduce individual morbidity and transmission from present rates and increase herd protection. Expand
...
1
2
3
4
5
...